Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J09L | ISIN: US85916J4094 | Ticker-Symbol: RJR1
Tradegate
27.01.25
15:04 Uhr
2,300 Euro
+0,200
+9,52 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
STEREOTAXIS INC Chart 1 Jahr
5-Tage-Chart
STEREOTAXIS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,1602,22020:43
2,1602,22020:40

Aktuelle News zur STEREOTAXIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
STEREOTAXIS Aktie jetzt für 0€ handeln
18:15Stereotaxis Magic ablation catheter is now CE mark approved1
16:29Stereotaxis Hikes on Winning European Approval1
14:06Stereotaxis, Inc.: Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter40ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received...
► Artikel lesen
14.01.Stereotaxis, Inc.: Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology2
09.12.24Stereotaxis wins approval in China for magnetic ablation catheter3
09.12.24Stereotaxis, Inc.: Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA3
02.12.24Stereotaxis, Inc.: Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems2
25.11.24Stereotaxis surgical robot earns regulatory nod in China2
25.11.24Stereotaxis, Inc.: Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China155ST. LOUIS and SHANGHAI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd. (688351.SH, "MicroPort EP"), today announced regulatory approval of the...
► Artikel lesen
20.11.24Hospital in Portugal adopts Stereotaxis surgical robot2
20.11.24Stereotaxis, Inc.: Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System1
14.11.24Stereotaxis, Inc. - 10-Q, Quarterly Report-
11.11.24Stereotaxis GAAP EPS of -$0.08 misses by $0.02, revenue of $9.2M beats by $2.1M1
11.11.24Stereotaxis, Inc.: Stereotaxis Reports 2024 Third Quarter Financial Results71ST. LOUIS, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results...
► Artikel lesen
10.11.24Stereotaxis Q3 2024 Earnings Preview2
08.11.24Stereotaxis Earnings Preview2
06.11.24Kansas hospital begins robotic heart program with Stereotaxis surgical robot1
06.11.24Stereotaxis, Inc.: University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology2
23.10.24Stereotaxis, Inc.: Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 20241
21.10.24Stereotaxis, Inc.: Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation2
Seite:  Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1